T. Anderson

Cardiology and Cardiovascular Medicine · Circulation · 2002–2021

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom T. Anderson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. T. Ivanova
  2. P. Ridker

Who trusts T. Anderson overall

  1. S. Verma

Papers from T. Anderson's perspective

Ordered by how strongly the researchers T. Anderson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
  2. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
  3. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. (New England Journal of Medicine)
  4. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
  5. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. (The Lancet)
  6. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (The Lancet)
  7. European guidelines on cardiovascular disease prevention in clinical practice
  8. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  9. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. (Journal of the American Medical Association (JAMA))
  10. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)

Their papers